Propanc Biopharma, Inc. (PPCB): Net Income
-$18.86M
Year ended 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$18.86M | n/m | 2026-09-25, From 2025-07-01 |
| 2025-06-30 | -$58.92M | n/m | 2026-09-25, From 2024-07-01 |
| 2024-06-30 | -$1.82M | n/m | 2025-09-29, From 2023-07-01 |
| 2023-06-30 | -$2.66M | n/m | 2024-09-30, From 2022-07-01 |
| 2022-06-30 | -$2.66M | n/m | 2023-09-28, From 2021-07-01 |
| 2021-06-30 | -$2.03M | n/c | 2022-09-28, From 2020-07-01 |
| 2020-06-30 | -$4.74M | n/m | 2021-09-28, From 2019-07-01 |
| 2019-06-30 | -$5.76M | n/m | 2020-10-01, From 2018-07-01 |
| 2018-06-30 | -$7.04M | n/m | 2019-10-15, From 2017-07-01 |
| 2017-06-30 | -$7.87M | n/m | 2018-09-17, From 2016-07-01 |
| 2016-06-30 | -$9.41M | n/m | 2017-09-28, From 2015-07-01 |
| 2015-06-30 | -$3.41M | n/m | 2016-09-28, From 2014-07-01 |
| 2014-06-30 | -$829.6K | n/m | 2015-09-30, From 2013-07-01 |
| 2013-06-30 | -$1.44M | n/m | 2014-10-14, From 2012-07-01 |
| 2012-06-30 | -$11.43M | n/m | 2013-10-15, From 2011-07-01 |
| 2011-06-30 | -$2.15M | n/m | 2013-10-15, From 2010-07-01 |
| 2010-06-30 | -$842.5K | n/m | 2013-10-15, From 2009-07-01 |
| 2009-06-30 | -$443.8K | n/a | 2013-10-15, From 2008-07-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Propanc Biopharma, Inc. (PPCB) | 2026-06-30 | -$18.86M | n/m |
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | -$6.08M | n/m |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | -$7.75M | n/m |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | -$28.62M | n/m |
| Imunon, Inc. (IMNN) | 2025-12-31 | -$14.50M | n/m |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | -$3.19M | n/m |
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | -$8.48M | n/m |
| Edesa Biotech, Inc. (EDSA) | 2025-09-30 | -$7.19M | n/m |
| CalciMedica, Inc. (CALC) | 2025-12-31 | -$29.56M | n/m |
Compare PPCB, NMAD, ELAB, NRXP side by side · Screen every company in Pharmaceutical Preparations ↗